XORTX Therapeutics (XRTX) Assets Average (2021 - 2026)
XORTX Therapeutics' (XRTX) quarterly Assets Average came in at $2.4 million in Q1 2026, down 36.41% YoY from $3.8 million in Q1 2025, and down 12.13% on a QoQ basis from $2.7 million in Q4 2025.
XORTX Therapeutics (XRTX) Assets Average (2021 - 2026) Analysis & Trends
XORTX Therapeutics (XRTX) has 6 years of Assets Average data on file, last reported at $2.4 million in Q1 2026.
- Quarterly Assets Average fell 36.41% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (down 36.41% YoY) and the FY2025 annual result came in at $3.4 million, down 29.12% from the prior year.
- Assets Average slipped to $2.4 million in Q1 2026, from $2.7 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $16.0 million in Q1 2022 to a low of $2.4 million in Q1 2026.
- A 5-year average of $7.3 million and a median of $5.4 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average gained 0.46% — and 2025, when it slumped 42.48%.
- Tracing XRTX's Assets Average over 5 years: stood at $11.9 million in 2022, then sank by 39.36% to $7.2 million in 2023, then tumbled by 44.99% to $4.0 million in 2024, then plunged by 30.84% to $2.7 million in 2025, then slipped by 12.13% to $2.4 million in 2026.
- The last three Assets Average figures came in at $2.4 million (Q1 2026), $2.7 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.19 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.58 Bn | 77.59 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.34 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.52 Bn | 51.38 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.67 Bn | 27.36 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.27 Bn | 26.11 Bn | 358.27 Mn | 2.09 Bn |
| 8 | BioNTech SE | 27.14 Bn | 8.75 Bn | 668.28 Mn | 25.27 Bn |
| 9 | Royalty Pharma | 27.12 Bn | 26.28 Bn | - | 19.82 Bn |
| 10 | XORTX Therapeutics | 2.78 Mn | 2.78 Mn | - | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.41 Mn |
| Dec 31, 2025 | 2.75 Mn |
| Sep 30, 2025 | 2.78 Mn |
| Jun 30, 2025 | 3.12 Mn |
| Mar 31, 2025 | 3.80 Mn |
| Dec 31, 2024 | 3.97 Mn |
| Sep 30, 2024 | 4.32 Mn |
| Jun 30, 2024 | 5.42 Mn |
| Sep 30, 2023 | 7.22 Mn |
| Jun 30, 2023 | 8.73 Mn |
| Mar 31, 2023 | 11.00 Mn |
| Dec 31, 2022 | 11.91 Mn |
| Sep 30, 2022 | 12.03 Mn |
| Jun 30, 2022 | 13.57 Mn |
| Mar 31, 2022 | 16.02 Mn |
| Dec 31, 2021 | 11.85 Mn |